Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Myelin Proteolipid Protein Complexes with αv Integrin and AMPA Receptors In Vivo and Regulates AMPA-Dependent Oligodendrocyte Progenitor Cell Migration through the Modulation of Cell-Surface GluR2 Expression.
Laquinimod (ABR-215062) for the treatment of relapsing multiple sclerosis.
The cost of multiple sclerosis drugs in the US and the pharmaceutical industry: Too big to fail?
The cost of medication and the cost of treatment are not the same thing for multiple sclerosis.
Working memory performance of early MS patients correlates inversely with modularity increases in resting state functional connectivity networks.
Serum vitamin d levels in Indian patients with multiple sclerosis.
Acceleration of conduction velocity linked to clustering of nodal components precedes myelination.
Reduced serum vitamin D levels in neuromyelitis optica.
Experimental autoimmune encephalomyelitis.
A comparison of linear and nonlinear stability parameters in different clinical forms of multiple sclerosis.
A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.
Therapeutic options in neuromyelitis optica spectrum disorders.
Depletion of brain functional connectivity enhancement leads to disability progression in multiple sclerosis: A longitudinal resting-state fMRI study.
A tetramethoxychalcone from Chloranthus henryi suppresses lipopolysaccharide-induced inflammatory responses in BV2 microglia.
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.
Regnase-1 in microglia negatively regulates high mobility group box 1-mediated inflammation and neuronal injury.
MRI outcomes in the diagnosis and disease course of multiple sclerosis.
Site-Specific Chemokine Expression Regulates Central Nervous System Inflammation and Determines Clinical Phenotype in Autoimmune Encephalomyelitis.
Association analysis of nitric oxide synthases: NOS1, NOS2A and NOS3 genes, with multiple sclerosis.
Nutritional factors and aging in demyelinating diseases.
Acid-Sensing Ion Channels Contribute to Neurotoxicity.
Regulation of IL-17 in autoimmune diseases by transcriptional factors and microRNAs.
[TERIFLUNOMIDE: NEW ORAL IMMUNMODULANT DRUG IN THERAPY OF MULTIPLE SCLEROSIS].
[Diagnostic criteria to patients with multiple sclerosis and clinically isolated syndrome].
Liver Damage and Mortality in a Male Lewis Rat of Experimental Autoimmune Encephalomyelitis.
Pages
« first
‹ previous
…
643
644
645
646
647
648
649
650
651
…
next ›
last »